Cara Therapeutics financials at a glance
| Year | Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2013 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$3.18M | $3.80M | $0.09M | $0.91M | $13.47M | $19.89M | $135.08M | $23.03M | $41.87M | $20.97M | $11.96M | $0.00M |
| GM % | Gross Margin % |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 20.16% | -259.13% | -134.09% | 70.56% | 27.41% | 0.00% |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3.99% | 0.00% | -209.08% | 0.00% | -1.98% | 0.00% |
| EPS | Earnings Per Share |
|
$-0.74 | $-0.85 | $-1.00 | $-2.10 | $-1.86 | $-2.06 | $-2.49 | $0.18 | $-1.74 | $-1.59 | $-2.19 | $0.00 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | -0.00% | -0.00% | 0.00% | -0.00% | -0.00% | 0 | 0 | 0 |
| Sha. | Shares |
|
22.78m | 27.23m | 27.28m | 32.61m | 39.45m | 46.68m | 49.83m | 53.46m | 53.59m | 0m | 0m | 54.48m |
| OCF | Operating Cash Flow |
|
$-17.64M | $-21.48M | $-47.38M | $-54.83M | $-22.30M | $-109.23M | $-5.49M | $-60.09M | $-78.73M | $-92.08M | $2.83M | $0.00M |
| FCF | Free Cash Flow |
|
$-17.68M | $-21.50M | $-48.10M | $-54.89M | $-22.37M | $-109.24M | $-5.84M | $-60.13M | $-78.77M | $-84.70M | $2.82M | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$-0.84 | $-0.87 | $-1.76 | $-1.76 | $-0.62 | $-2.56 | $-0.12 | $-1.19 | $-1.47 | $-1.74 | $0.68 | $0.00 |